Potential association of obesity with IL6 G-174C polymorphism and TTV infections

Central European Journal of Biology

Volumn 8, Issue 7, 2013, Pages 625-632

  Cimponeriu, Danut ^a   Serafinceanu, Cristian ^b   Apostol, Pompilia ^a   Toma, Mihai ^a   Stavarachi, Monica ^a   Radu, Irina ^a   Craciun, Anne M ^b   Spandole, Sonia ^a   Nicolae, Panduru ^c   Rusu, Lavinia ^d   Schiopu, Oana M ^c   Ion, Daniela A ^c  

^a UNIVERSITY OF BUCHAREST   (Romania)

^b N Paulescu National Institute of Diabetes Nutrition and Metabolic Diseases   (Romania)

^c CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^d National Institute of Research and Development for Food Bioresources   (Romania)

Author keywords

ACE; AT1R; IL6; Obesity; Polymorphisms; TTV

Indexed keywords

TORQUE TENO VIRUS;

EID: 84876512817     PISSN: 1895104X     EISSN: 16443632     Source Type: Journal    
DOI: 10.2478/s11535-013-0178-1     Document Type: Article

References (72)

1. Pasarica M., Dhurandhar N. V., Infectobesity: obesity of infectious origin, Adv. Food. Nutr. Res., 2007, 52, 61-102.
2. Cousin B., Munoz O., Andre M., Fontanilles A. M., Dani C., Cousin J. L., et al., A role for preadipocytes as macrophage-like cells, FASEB J., 1999, 13, 305-312.
3. Levitan R. D., Masellis M., Lam R. W., Kaplan A. S., Davis C., Tharmalingam S., et al., A birthseason/DRD4 gene interaction predicts weight gain and obesity in women with seasonal affective disorder: A seasonal thrifty phenotype hypothesis, Neuropsychopharmacology, 2006, 31, 2498-2503.
4. Phillips D. I., Young J. B., Birth weight, climate at birth and the risk of obesity in adult life, Int. J. Obes. Relat. Metab. Disord., 2000, 24, 281-287.
5. van Ginneken V., Sitnyakowsky L., Jeffery J. E., Infectobesity: viral infections (especially with human adenovirus-36: Ad-36) may be a cause of obesity, Med. Hypotheses., 2009, 72, 383-388.
6. Nishizawa T., Okamoto H., Konishi K., Yoshizawa H., Miyakawa Y., Mayumi M., A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology, Biochem. Biophys. Res. Commun., 1997, 241, 92-97.
7. Pollicino T., Raffa G., Squadrito G., Costantino L., Cacciola I., Brancatelli S., et al., TT virus has a ubiquitous diffusion in human body tissues: analyses of paired serum and tissue samples, J. Viral. Hepat., 2003, 10, 95-102.
8. Eder K., Baffy N., Falus A., Fulop A. K., The major inflammatory mediator interleukin-6 and obesity, Inflamm. Res., 2009, 58, 727-736.
9. Qi L., Zhang C., van Dam R. M., Hu F. B., Interleukin-6 genetic variability and adiposity: associations in two prospective cohorts and systematic review in 26, 944 individuals, J. Clin. Endocrinol. Metab., 2007, 92, 3618-3625.
10. Stelzer I., Zelzer S., Raggam R. B., Pruller F., Truschnig-Wilders M., Meinitzer A., et al., Link between leptin and interleukin-6 levels in the initial phase of obesity related inflammation, Transl. Res., 2012, 159, 118-124.
11. Berthier M. T., Paradis A. M., Tchernof A., Bergeron J., Prud'homme D., Despres J. P., et al., The interleukin 6-174G/C polymorphism is associated with indices of obesity in men, J. Hum. Genet., 2003, 48, 14-19.
12. Klipstein-Grobusch K., Mohlig M., Spranger J., Hoffmann K., Rodrigues F. U., Sharma A. M., et al., Interleukin-6 g.-174G> C promoter polymorphism is associated with obesity in the EPIC-Potsdam Study, Obesity (Silver Spring), 2006, 14, 14-18.
13. Moffett S. P., Zmuda J. M., Cauley J. A., Stone K. L., Nevitt M. C., Ensrud K. E., et al., Association of the G-174C variant in the interleukin-6 promoter region with bone loss and fracture risk in older women, J. Bone. Miner. Res., 2004, 19, 1612-1618.
14. Stephens J. W., Hurel S. J., Cooper J. A., Acharya J., Miller G. J., Humphries S. E., A common functional variant in the interleukin-6 gene is associated with increased body mass index in subjects with type 2 diabetes mellitus, Mol. Genet. Metab., 2004, 82, 180-186.
15. Wernstedt I., Eriksson A. L., Berndtsson A., Hoffstedt J., Skrtic S., Hedner T., et al., A common polymorphism in the interleukin-6 gene promoter is associated with overweight, Int. J. Obes. Relat. Metab. Disord., 2004, 28, 1272-1279.
16. Bennermo M., Held C., Stemme S., Ericsson C. G., Silveira A., Green F., et al., Genetic predisposition of the interleukin-6 response to inflammation: implications for a variety of major diseases?, Clin. Chem., 2004, 50, 2136-2140.
17. Schling P., Mallow H., Trindl A., Loffler G., Evidence for a local renin angiotensin system in primary cultured human preadipocytes, Int. J. Obes. Relat. Metab. Disord., 1999, 23, 336-341.
18. Engeli S., Gorzelniak K., Kreutz R., Runkel N., Distler A., Sharma A. M., Co-expression of reninangiotensin system genes in human adipose tissue, J. Hypertens., 1999, 17, 555-560.
19. Phillips M. I., Kagiyama S., Angiotensin II as a proinflammatory mediator, Curr. Opin. Investig. Drugs, 2002, 3, 569-577.
20. de Kloet A. D., Krause E. G., Woods S. C., The renin angiotensin system and the metabolic syndrome, Physiol. Behav., 2010, 100, 525-534.
21. Goossens G. H., Blaak E. E., van Baak M. A., Possible involvement of the adipose tissue reninangiotensin system in the pathophysiology of obesity and obesity-related disorders, Obes. Rev., 2003, 4, 43-55.
22. Nickenig G., Roling J., Strehlow K., Schnabel P., Bohm M., Insulin induces upregulation of vascular AT1 receptor gene expression by posttranscriptional mechanisms, Circulation, 1998, 98, 2453-2460.
23. Barton M., Carmona R., Ortmann J., Krieger J. E., Traupe T., Obesity-associated activation of angiotensin and endothelin in the cardiovascular system, Int. J. Biochem. Cell Biol., 2003, 35, 826-837.
24. Ye S., Dhillon S., Ke X., Collins A. R., Day I. N., An efficient procedure for genotyping single nucleotide polymorphisms, Nucleic Acids Res., 2001, 29, E88-88.
25. Tiret L., Rigat B., Visvikis S., Breda C., Corvol P., Cambien F., et al., Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels, Am. J. Hum. Genet., 1992, 51, 197-205.
26. Doria A., Ji L., Warram J. H., Krolewski A. S., DdeI polymorphism in the AGTR1 gene, Hum. Mol. Genet., 1994, 3, 1444.
27. Lindpaintner K., Pfeffer M. A., Kreutz R., Stampfer M. J., Grodstein F., LaMotte F., et al., A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease, N. Engl. J. Med., 1995, 332, 706-711.
28. Ninomiya M., Takahashi M., Nishizawa T., Shimosegawa T., Okamoto H., Development of PCR assays with nested primers specific for differential detection of three human anelloviruses and early acquisition of dual or triple infection during infancy, J. Clin. Microbiol., 2008, 46, 507-514.
29. Schoonjans F., Zalata A., Depuydt C. E., Comhaire F. H., MedCalc: a new computer program for medical statistics, Comput. Methods Programs Biomed., 1995, 48, 257-262.
30. Terry C. F., Loukaci V., Green F. R., Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation, J. Biol. Chem., 2000, 275, 18138-18144.
31. Yang X., Jansson P. A., Pellme F., Laakso M., Smith U., Effect of the interleukin-6 (-174) g/c promoter polymorphism on adiponectin and insulin sensitivity, Obes. Res., 2005, 13, 813-817.
32. van Geel P. P., Pinto Y. M., Voors A. A., Buikema H., Oosterga M., Crijns H. J., et al., Angiotensin II type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries, Hypertension, 2000, 35, 717-721.
33. Zheng H., Ye L., Fang X., Li B., Wang Y., Xiang X., et al., Torque teno virus (SANBAN isolate) ORF2 protein suppresses NF-kappaB pathways via interaction with IkappaB kinases, J. Virol., 2007, 81, 11917-11924.
34. Batra A., Pietsch J., Fedke I., Glauben R., Okur B., Stroh T., et al., Leptin-dependent toll-like receptor expression and responsiveness in preadipocytes and adipocytes, Am. J. Pathol., 2007, 170, 1931-1941.
35. Rocchi J., Ricci V., Albani M., Lanini L., Andreoli E., Macera L., et al., Torquetenovirus DNA drives proinflammatory cytokines production and secretion by immune cells via toll-like receptor 9, Virology, 2009, 394, 235-242.
36. Yokoyama H., Yasuda J., Okamoto H., Iwakura Y., Pathological changes of renal epithelial cells in mice transgenic for the TT virus ORF1 gene, J. Gen. Virol., 2002, 83, 141-150.
37. De Benedetti F., Alonzi T., Moretta A., Lazzaro D., Costa P., Poli V., et al., Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation, J. Clin. Invest., 1997, 99, 643-650.
38. Barker D. J., Eriksson J. G., Forsen T., Osmond C., Fetal origins of adult disease: strength of effects and biological basis, Int. J. Epidemiol., 2002, 31, 1235-1239.
39. Fried S. K., Bunkin D. A., Greenberg A. S., Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid, J. Clin. Endocrinol. Metab., 1998, 83, 847-850.
40. Fain J. N., Madan A. K., Hiler M. L., Cheema P., Bahouth S. W., Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans, Endocrinology, 2004, 145, 2273-2282.
41. Fain J. N., Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells, Vitam. Horm., 2006, 74, 443-477.
42. Rexrode K. M., Pradhan A., Manson J. E., Buring J. E., Ridker P. M., Relationship of total and abdominal adiposity with CRP and IL-6 in women, Ann. Epidemiol., 2003, 13, 674-682.
43. Vozarova B., Weyer C., Hanson K., Tataranni P. A., Bogardus C., Pratley R. E., Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion, Obes. Res., 2001, 9, 414-417.
44. Manco M., Fernandez-Real J. M., Equitani F., Vendrell J., Valera Mora M. E., Nanni G., et al., Effect of massive weight loss on inflammatory adipocytokines and the innate immune system in morbidly obese women, J. Clin. Endocrinol. Metab., 2007, 92, 483-490.
45. Wisse B. E., The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity, J. Am. Soc. Nephrol., 2004, 15, 2792-2800.
46. van Hall G., Steensberg A., Sacchetti M., Fischer C., Keller C., Schjerling P., et al., Interleukin-6 stimulates lipolysis and fat oxidation in humans, J. Clin. Endocrinol. Metab., 2003, 88, 3005-3010.
47. Trujillo M. E., Sullivan S., Harten I., Schneider S. H., Greenberg A. S., Fried S. K., Interleukin-6 regulates human adipose tissue lipid metabolism and leptin production in vitro, J. Clin. Endocrinol. Metab., 2004, 89, 5577-5582.
48. Path G., Bornstein S. R., Gurniak M., Chrousos G. P., Scherbaum W. A., Hauner H., Human breast adipocytes express interleukin-6 (IL-6) and its receptor system: increased IL-6 production by beta-adrenergic activation and effects of IL-6 on adipocyte function, J. Clin. Endocrinol. Metab., 2001, 86, 2281-2288.
49. Plata-Salaman C. R., Immunoregulators in the nervous system, Neurosci. Biobehav. Rev., 1991, 15, 185-215.
50. Wallenius V., Wallenius K., Ahren B., Rudling M., Carlsten H., Dickson S. L., et al., Interleukin-6-deficient mice develop mature-onset obesity, Nat. Med., 2002, 8, 75-79.
51. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J. S., Humphries S., et al., The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis, J. Clin. Invest., 1998, 102, 1369-1376.
52. Ray A., Tatter S. B., May L. T., Sehgal P. B., Activation of the human "beta 2-interferon/hepatocytestimulating factor/interleukin 6" promoter by cytokines, viruses, and second messenger agonists, Proc. Natl. Acad. Sci. U S A, 1988, 85, 6701-6705.
53. Isshiki H., Akira S., Tanabe O., Nakajima T., Shimamoto T., Hirano T., et al., Constitutive and interleukin-1 (IL-1)-inducible factors interact with the IL-1-responsive element in the IL-6 gene, Mol. Cell. Biol., 1990, 10, 2757-2764.
54. Kopf M., Baumann H., Freer G., Freudenberg M., Lamers M., Kishimoto T., et al., Impaired immune and acute-phase responses in interleukin-6-deficient mice, Nature, 1994, 368, 339-342.
55. Kopf M., Ramsay A., Brombacher F., Baumann H., Freer G., Galanos C., et al., Pleiotropic defects of IL-6-deficient mice including early hematopoiesis, T and B cell function, and acute phase responses, Ann. N Y Acad. Sci., 1995, 308-318.
56. Vasilyev E. V., Trofimov D. Y., Tonevitsky A. G., Ilinsky V. V., Korostin D. O., Rebrikov D. V., Torque Teno Virus (TTV) distribution in healthy Russian population, Virol. J., 2009, 6, 134-138.
57. Urwijitaroon Y., Barusrux S., Chunlertlith K., Mairiang P., Yoshimura H., Torquetenovirus infection among northeastern Thai blood donors, Southeast Asian J. Trop. Med. Public Health, 2007, 38, 686-689.
58. Al-Moslih M. I., Abuodeh R. O., Hu Y. W., Detection and genotyping of TT virus in healthy and subjects with HBV or HCV in different populations in the United Arab Emirates, J. Med. Virol., 2004, 72, 502-508.
59. Odemis E., Gurakan F., Ergunay K., Yuce A., Ozen H., Kocak N., TTV infection in children with and without liver disease, Indian J. Gastroenterol., 2004, 23, 135-137.
60. Thomas G. N., Tomlinson B., Chan J. C., Sanderson J. E., Cockram C. S., Critchley J. A., Reninangiotensin system gene polymorphisms, blood pressure, dyslipidemia, and diabetes in Hong Kong Chinese: a significant association of tne ACE insertion/deletion polymorphism with type 2 diabetes, Diabetes Care, 2001, 24, 356-361.
61. Kim K., Association of angiotensin-converting enzyme insertion/deletion polymorphism with obesity, cardiovascular risk factors and exercisemediated changes in Korean women, Eur. J. Appl. Physiol., 2009, 105, 879-887.
62. Alavi-Shahri J., Behravan J., Hassany M., Tatari F., Kasaian J., Ganjali R., et al., Association between angiotensin II type 1 receptor gene polymorphism and metabolic syndrome in a young female Iranian population, Arch. Med. Res., 2010, 41, 343-349.
63. Manea S. A., Robciuc A., Guja C., Heltianu C., Identification of gene variants in NOS3, ET-1 and RAS that confer risk and protection against microangiopathy in type 2 diabetic obese subjects, Biochem. Biophys. Res. Commun., 2011, 407, 486-490.
64. Eisenmann J. C., Sarzynski M. A., Glenn K., Rothschild M., Heelan K. A., ACE I/D genotype, adiposity, and blood pressure in children, Cardiovasc. Diabetol., 2009, 8, 14-22.
65. Lagou V., Manios Y., Moran C. N., Bailey M. E., Grammatikaki E., Oikonomou E., et al., Developmental changes in adiposity in toddlers and preschoolers in the GENESIS study and associations with the ACE I/D polymorphism, Int. J. Obes. (Lond.), 2007, 31, 1052-1060.
66. Strazzullo P., Iacone R., Iacoviello L., Russo O., Barba G., Russo P., et al., Genetic variation in the renin-angiotensin system and abdominal adiposity in men: the Olivetti Prospective Heart Study, Ann. Intern. Med., 2003, 138, 17-23.
67. Abdollahi M. R., Gaunt T. R., Syddall H. E., Cooper C., Phillips D. I., Ye S., et al., Angiotensin II type I receptor gene polymorphism: anthropometric and metabolic syndrome traits, J. Med. Genet., 2005, 42, 396-401.
68. Niel C., de Oliveira J. M., Ross R. S., Gomes S. A., Roggendorf M., Viazov S., High prevalence of TT virus infection in Brazilian blood donors, J. Med. Virol., 1999, 57, 259-263.
69. Maggi F., Andreoli E., Lanini L., Fornai C., Vatteroni M., Pistello M., et al., Relationships between total plasma load of torquetenovirus (TTV) and TTV genogroups carried, J. Clin. Microbiol., 2005, 43, 4807-4810.
70. Parra-Rojas I., Ruiz-Madrigal B., Martinez-Lopez E., Panduro A., Influence of the -308 TNF-alpha and -174 IL-6 polymorphisms on lipid profile in Mexican subjects, Hereditas, 2006, 143, 167-172.
71. Comas D., Schmid H., Braeuer S., Flaiz C., Busquets A., Calafell F., et al., Alu insertion polymorphisms in the Balkans and the origins of the Aromuns, Ann. Hum. Genet., 2004, 68, 120-127.
72. Thameem F., Voruganti V. S., He X., Nath S. D., Blangero J., MacCluer J. W., et al., Genetic variants in the renin-angiotensin system genes are associated with cardiovascular-renal-related risk factors in Mexican Americans, Hum. Genet., 2008, 124, 557-559.